Japanese R&D expenditures decrease for first time in 3 years
Academic research in Japan perceive bias in lab funding.
Korean Ministry of Science, ICT and Future Planning releases new R&D expenditure data
Singapore continues steady progress to becoming Asian hub of R&D
Ministry of Science, ICT and Future Planning increases 2017 science and tech budget
Based on R&D data submitted by the 10 largest pharmaceutical companies in South Korea, in 2015, the average rate of pharmaceutical R&D expenditure was 10.46% of their revenues. Revenues for the 10 companies was KRW 7.5 trillion ($6 billion), with total R&D expenditure of KRW 774 billion ($672 million). Of the 10 companies, seven invested […]
Sequencing in China is on a rapid rise, with the country accounting for 20%–30% of global sequencing capacity. Driving this growth is China’s 15-year precision medicine program (see IBO 1/31/16). The multi-billion dollar budget of the initiative will be used for improving precision medicine technology, sequencing, analyzing over a million human genomes, and drug development […]
In 1999, R&D made up 2.07% of South Korea’s GDP and by 2014, that number reached 4.29%, or $60.5 billion. This makes South Korea the global leader in R&D investment as a percentage of GDP, followed by Israel, Japan, the US, China and the EU. By 2017, the country plans to increase R&D investment to […]
Analytical instrument and lab product company executives’ expectations have diminished since last fall, according to the latest IBO Business Climate Survey. This is not a surprise considering updated macroeconomic forecasts. In April, the International Monetary Fund revised its January projections for global growth downward two-tenths of a percentage point to 3.2%. This followed a February […]
By 2020, the Chinese pharmaceutical market is projected to be valued at $120 billion, although the lack of R&D in the industry is currently holding back further growth and innovation. This is due largely in part to slow regulatory and review processes that can delay drug approvals for up to eight years. The China Food […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
